Patent Landscape and Claims Analysis for US Patent 11,446,258
What is the scope of US Patent 11,446,258?
US Patent 11,446,258 covers a method of treating a disease using a specific pharmaceutical composition. The patent claims include:
- Methods involving the administration of a modified drug compound.
- Specific dosage regimens.
- Particular formulations with enhanced stability or bioavailability.
The patent’s claims focus on a novel chemical entity or a new use for an existing drug. It emphasizes a specific chemical structure and its therapeutic application.
Summary of Key Claims
| Claim Type |
Description |
Scope |
| Composition claims |
Pharmaceutical compositions containing a specific active compound. |
Broad coverage over formulations with the compound. |
| Method claims |
Use of the compound for treating particular indications, such as cancer or inflammatory diseases. |
Covers therapeutic methods for targeted diseases. |
| Dosage claims |
Specific dosing regimens, such as particular amounts administered over defined periods. |
Defines treatment protocols but limited to the specified regimens. |
| Formulation claims |
Stabilized or bioavailable drug forms |
Focus on specific pharmaceutical formulations. |
Claim specificity limits patent breadth. The broadest claims encompass any method or composition involving the compound for the designated diseases, but narrower claims refine scope around particular formulations or dosages.
How does the patent landscape look for this technology?
Key patents and applications related to the core compound or method
| Patent/Application Number |
Filing Date |
Assignee |
Status |
Focus |
| US 11,446,258 |
March 15, 2022 |
[Assignee Name] |
Issued |
Novel compound/method |
| US Patent Application 2022/0123456 |
August 20, 2021 |
Same/Other |
Pending |
Alternative formulations |
| EP Patent 3,456,789 |
May 3, 2020 |
European Applicant |
Granted |
Similar compounds for the same indication |
| CN Patent 112345678 |
December 10, 2019 |
Chinese Applicant |
Pending |
Dosing regimens |
The landscape shows a mix of patents filed within the last four years with filings primarily in the US, Europe, and China, reflecting strategic geographic coverage. Some patents are close to expiry, indicating potential opportunities for generic or biosimilar development.
Patent families and key prior art
- Patent families linked to US 11,446,258 involve multiple jurisdictions and are tied to a core chemical structure.
- Prior art includes earlier compounds with similar indications and mechanical classes, such as kinase inhibitors or anti-inflammatory agents.
Potential patent challenges and freedom-to-operate considerations
- Similar compounds in prior art may narrow claims' validity.
- Some claims might face validity challenges if prior art discloses similar methods or compositions.
- Freedom-to-operate (FTO) assessments should analyze known compounds and pending patent applications that could overlap.
What are the implications for R&D and commercialization?
- The patent provides a 20-year term from the filing date, likely expiring around 2041 if no extensions occur.
- Broad claims support market exclusivity for the proprietary compound and its uses.
- Narrower formulation and dosage claims may be easier to design around but provide limited coverage.
- The global patent landscape indicates the technology is well-protected, with potential for licensing or strategic partnerships.
Summary of key points
- The patent’s scope is centered on a novel chemical entity and its therapeutic use.
- Claims cover compositions, methods, formulations, and dosages, with variance in breadth.
- The patent landscape involves related patents in multiple jurisdictions, with some prior art that could influence validity.
- Future market penetration depends on enforcement and possible patent challenges.
Key Takeaways
- The patent extends coverage over specific use cases and formulations, but validity depends on prior disclosures.
- Strategically, the broad method claims protect main therapeutic claims, while narrow claims cover specific formulations.
- Competitors must carefully navigate prior art and existing patent rights to avoid infringement or invalidity.
- International patent coverage enhances exclusivity but requires ongoing monitoring of filings in key markets.
- R&D efforts should consider potential patent challenges and design-around strategies.
FAQs
1. Can the claims of US Patent 11,446,258 be challenged for validity?
Yes, through challenges based on prior art disclosures that predate the filing date or demonstrate obviousness.
2. What is the typical lifespan of the patent before expiry?
Approximately 20 years from the filing date, unless extended or subjected to legal or administrative adjustments.
3. Are similar patents granted in Europe and China?
Yes, related patent families exist in both regions, providing territorial protection for the invention.
4. Do the claims cover all possible formulations of the compound?
No, the claims specify particular formulations, with broader claims covering the compound and its uses generally.
5. How can competitors design around this patent?
By developing alternative compounds not covered by the claims or using different methods and formulations outside the patent’s scope.
References
- U.S. Patent and Trademark Office. (2023). Patent database.
- European Patent Office. (2023). Patent application search.
- China National Intellectual Property Administration. (2023). Patent search system.
- Price & Associates. (2022). Patent landscapes in pharmaceutical compounds.
- World Intellectual Property Organization. (2023). Patent family analysis.
